Apoptosis: giving phosphatidylserine recognition an assist – with a twist  by Fadok, Valerie A. & Henson, Peter M.
Apoptosis: Giving Phosphatidylserine
Recognition an Assist — with a Twist
Valerie A. Fadok and Peter M. Henson
Recognition of exposed phosphatidylserine on
apoptotic cells is critical for their removal. A recent
study suggests that annexin I is also externalized on
apoptotic cells and may enhance phagocytosis of
dying cells through the phosphatidylserine receptor.
Clearance of dying cells is critical to tissue homeosta-
sis in the multicellular organism. In recent years, accu-
mulating data have suggested that removal of
apoptotic cells is a two-stage process. First, cellular
corpses are neatly packaged for recognition during
the process of apoptosis. Their uptake by phagocytes
(either macrophages or tissue cells) prevents the
eventual release of potent proinflammatory intracellu-
lar contents, as well as intracellular materials that may
be proimmunogenic. A second process involves the
induction of an active anti-inflammatory response in
the phagocyte following binding to the cellular corpse.
Both the uptake and anti-inflammatory responses
appear to require that the dying cell lose phospholipid
asymmetry, thus exposing phosphatidylserine (PS) on
the external leaflet of the plasma membrane [1,2]. Pre-
venting loss of phospholipid asymmetry or blocking
exposed PS with annexin V appears to abrogate both
uptake of the cell corpse and release of anti-inflam-
matory mediators [1,3,4]. These two processes can be
separated, however, because cells that engulf apop-
totic cells inefficiently can still respond with a robust
production of anti-inflammatory mediators. Moreover,
specific stimulation of the PS receptor with an agonis-
tic monoclonal antibody stimulates release of anti-
inflammatory mediators, as does exposure to
liposomes containing the L, but not D, stereoisomers
of PS.
Many phagocyte receptors have been implicated in
the removal of apoptotic cells, and in many cases the
ligands they recognize are not known. Why there are
so many receptors for removal and how these recep-
tors interact with their targets is an active area of
research. Adding a level of complexity, several bridg-
ing molecules linking specific receptors on the phago-
cyte to ligands on the dying cell appear to increase
the efficiency of uptake. In many cases, these are
known PS-binding proteins, such as the serum pro-
teins β2 glycoprotein 1 (β2GP1) [5] and protein S
(involved in anti-coagulation) [6], the growth arrest
specific gene product GAS-6 [7], complement activa-
tion products [8] and the milk fat globule protein MFG-
E8 [9]. In the cases of β2GP1 and protein S, the
receptors on the phagocyte to which these proteins
bind have not yet been identified. GAS-6 is a ligand for
the receptor tyrosine kinase MER, reported to be
involved in engulfment of apoptotic cells [10], whereas
MFG-E8 is believed to bind to αvβ3 [9], the vitronectin
receptor implicated in the recognition and uptake of
apoptotic cells many years ago by Savill and col-
leagues [11]. A few years ago, Reutlingsperger posed
the hypothesis that annexins might also serve to
bridge apoptotic cells to hungry phagocytes (C. Reut-
lingsperger, personal communication). Now, a recent
paper from Arur and colleagues [12] supports that
hypothesis and adds a twist to the story: that annexin
I may serve to facilitate or enhance the recognition of
PS by the PS receptor. 
Using a quantitative proteomics approach, Arur et
al. [12] compared membranes from normal and apop-
totic cells. They found that expression of annexin I
protein was elevated in membranes from dying cells
compared with viable cells. While no annexin I could
be detected by immunofluorescence on the surface of
viable cells, apoptotic cells appeared to express this
protein in patches, reminiscent of the way in which
exogenously applied annexin V binds to exposed PS
on dying cells. Permeabilization of the cells showed
that annexin I was recruited to the membrane early in
apoptosis before its accumulation on the cell surface.
These findings were confirmed by cell fractionation
and western blotting. The translocation of annexin I
appeared to require activation of caspases as well as
an increase in intracellular calcium levels, but the
mechanism by which the protein is translocated
across the membrane remains mysterious. It is inter-
esting to note, however, that the ATP-binding cassette
transporter A1 (ABC A1), implicated in the recognition
and uptake of apoptotic cells by macrophages [13],
has also been linked to the externalization of annexin
I in pituitary folliculo-stellate cells [14].
A role for annexin I in uptake was confirmed by the
use of small interfering RNAs to reduce annexin I
expression in the dying cells. The efficiency of engulf-
ment of these cells was reduced by approximately
60%. Uptake of these annexin I-silenced apoptotic
cells was restored by adding exogenous annexin I,
further supporting a role for this protein in clearance.
Downregulation of the expression of the nematode
annexin I homologue, nex-I, impaired engulfment of
apoptotic cellular corpses in C. elegans as well, sup-
porting the idea of phylogenetic conservation of this
uptake pathway.
Following these data supporting a role for annexin I
bridging PS on apoptotic cells to phagocytes, Arur
and colleagues [12] then closed the loop by suggest-
ing involvement of the PS receptor in this uptake
pathway. Immunofluorescence studies revealed that
the PS receptor on phagocytes appeared to cluster
around the dying cell; this clustering was reduced
when the apoptotic cells had been silenced for
annexin I expression using siRNA.
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These interesting findings pose several questions.
First, what does the PS receptor see on apoptotic
cells? There is evidence that this PS receptor binds
preferentially to PS compared with other phospho-
lipids when coated on plates in an ELISA assay (V.A.F.
and D. Xue, unpublished data) in the absence of any
added protein. It is not clear how PS in an apoptotic
cell membrane is recognised by PSR on the phago-
cytic cell. Several of us have wondered how such a
small receptor molecule recognizes such an exceed-
ingly small polar head group on a membrane phos-
pholipid. Nevertheless, is there a ‘missing link’ that
facilitates the presentation of PS in an as yet unknown
configuration to the PS receptor on the phagocytes?
One could speculate that a membrane-associated
protein or proteins might enhance the physical array
of PS so that it is recognizable to a phagocyte as an
‘eat me’ signal. If true, the existence of such a protein
might be one of the explanations for why activated
cells, which express PS transiently, are not engulfed
by phagocytes. Is it possible that annexin I is the
missing link? Is the true ligand for the PS receptor
annexin I plus PS? Or could the PS receptor be asso-
ciated with the annexin I/lipocortin receptor proposed
several years ago? If so, the distinctive stereospeci-
ficity of the PSR, in contrast to many other lipid-
binding receptors, has to be explained. The molecular
interactions among these three molecules requires
elucidation (see Figure 1). More likely, one might spec-
ulate that annexin I is somehow involved in the move-
ment of PS from the inner to the outer leaflet of the
cell during apoptosis or that it aggregates PS in the
outer leaflet without necessarily bridging PS to PSR.
Does PS appear aggregated in annexin I deficient
cells as it does in wild-type cells?
Given that the PS receptor is required for engulf-
ment of apoptotic cells as well as the release of anti-
inflammatory mediators associated with binding to
apoptotic cells, and given that the anti-inflammatory
effects of apoptotic cells can be mimicked with
protein-free liposomes containing L, but not D
stereoisomers of PS, is annexin I important only for
efficiency of engulfment? Or does it also facilitate effi-
ciency of the anti-inflammatory response? Annexin I
(originally designated lipocortin) has a long history as
an anti-inflammatory molecule induced by glucocor-
ticoids. Originally believed to be an inhibitor of phos-
pholipases, it is now believed to inhibit the function of
these enzymes by binding to PS, and preventing its
interaction as cofactor with the phospholipase. Fur-
thermore, annexin I action is not restricted to the inhi-
bition of phospholipase activity; it is known to inhibit
a variety of inflammatory pathways. It will therefore
be critical to determine if silencing annexin I also
blocks the anti-inflammatory response induced by
apoptotic cells.
A third question concerns how annexin I bound to
the external surface of apoptotic cells facilitates
uptake in the face of the known ability of exogenously
added annexin V to block uptake. The answer may
relate to differences in thermodynamic properties
between the two proteins contributing to different
functions [15]. How PS in a cell membrane binds to
both these annexins as well as how it binds to the
PSR need to be clarified. Confirming a role for these
molecules in vivo remains a critical goal.
Why are there so many PS-binding proteins that
may be involved in phagocyte recognition of apoptotic
cells? In general, the dogma is that apoptotic cells are
anti-inflammatory. However, there are some scenarios
in which they have been shown to be proinflammatory
or proimmunogenic [16,17], particularly when used to
stimulate immunity against tumours (for example, see
[18–20]). Leaving out technical issues associated with
purity of apoptotic cell populations and content of
necrotic cells, these contrasting effects raise some
interesting possibilities. Do some of the PS-binding
proteins in fact block the anti-inflammatory effects of
PS? If so, the true effects of the apoptotic cell on
inflammation and immune response will be deter-
mined by how much PS is bound by these various
proteins in vivo versus how much is free, and whether
these proteins trigger anti-inflammatory or proinflam-
matory receptors on phagocytes.
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Figure 1. Three possibilities for interaction of annexin I with
phosphatidylserine receptor (PSR).
Annexin I is represented in red. An apoptotic cell stained with
annexin V (green) is surrounded by potential phagocytes. The
PSR (orange) might bind to exposed PS that is configured in a
recognizable ‘eat-me’ form by annexin I (bottom). Alternatively,
PSR might bind to a ligand composed of PS and annexin I
(upper left) or PSR might bind annexin I, which serves as a
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